U2Bio Co (XKRX:221800) Ending Cash Position : ₩15,663 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Ending Cash Position?

U2Bio Co's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩15,663 Mil.

U2Bio Co's quarterly Ending Cash Position increased from Dec. 2022 (₩-12,524 Mil) to Jun. 2023 (₩19,627 Mil) but then declined from Jun. 2023 (₩19,627 Mil) to Dec. 2023 (₩15,663 Mil).

U2Bio Co's annual Ending Cash Position declined from Dec. 2021 (₩16,485 Mil) to Dec. 2022 (₩1,433 Mil) but then increased from Dec. 2022 (₩1,433 Mil) to Dec. 2023 (₩35,290 Mil).

U2Bio Co Ending Cash Position Historical Data

The historical data trend for U2Bio Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Ending Cash Position Chart

U2Bio Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,337.41

4,501.63

16,484.67

1,432.76

35,290.50

U2Bio Co Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	13,957.01	-12,524.25	19,627.20	15,663.29

U2Bio Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

U2Bio Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1432.762	+	33857.733
	=	35,290

U2Bio Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-1.8189894035459E-12	+	15663.291
	=	15,663

U2Bio Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Basement 1, 68 Gumaro Songpagu, Seoul, KOR

Website

http://www.u2bio.co.kr

U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines